Who are placebo to metronidazole's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Metronidazole 400 (14 days), Ciprofloxacin Tablets & Metronidazole tablets, Antibiotics, cefuroxime and metronidazole, Metronidazole 400 (7 days), ceftriaxone sodium + metronidazole, Levornidazole Disodium Phosphate for Injection.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-to-metronidazole.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

placebo to metronidazole — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

placebo to metronidazole (placebo to metronidazole) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: nitroimidazole antibiotic. Area: Gastrointestinal.

phase 3 nitroimidazole antibiotic Gastrointestinal Small molecule Live · refreshed every 30 min

Target snapshot

placebo to metronidazole (placebo to metronidazole) — Merck Sharp & Dohme LLC. Metronidazole is an antibiotic that works by stopping the growth of bacteria and protozoa.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
placebo to metronidazole TARGET	placebo to metronidazole	Merck Sharp & Dohme LLC	phase 3	nitroimidazole antibiotic
Metronidazole 400 (14 days)	Metronidazole 400 (14 days)	University of Guarulhos	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
Ciprofloxacin Tablets & Metronidazole tablets	Ciprofloxacin Tablets & Metronidazole tablets	MinaPharm Pharmaceuticals	marketed	Fluoroquinolone + Nitroimidazole antibiotic combination	Bacterial DNA gyrase, topoisomerase IV (ciprofloxacin); anaerobic DNA (metronidazole)
Antibiotics, cefuroxime and metronidazole	Antibiotics, cefuroxime and metronidazole	Helsinki University Central Hospital	marketed	Beta-lactam antibiotic + nitroimidazole antibiotic combination	Bacterial penicillin-binding proteins (cefuroxime); anaerobic bacterial DNA (metronidazole)
Metronidazole 400 (7 days)	Metronidazole 400 (7 days)	University of Guarulhos	marketed	Nitroimidazole antibiotic	Bacterial/parasitic DNA
ceftriaxone sodium + metronidazole	ceftriaxone sodium + metronidazole	Wyeth is now a wholly owned subsidiary of Pfizer	marketed	Beta-lactam antibiotic + nitroimidazole antibiotic combination	Bacterial penicillin-binding proteins (ceftriaxone); anaerobic bacterial DNA (metronidazole)
Levornidazole Disodium Phosphate for Injection	Levornidazole Disodium Phosphate for Injection	Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd	marketed	Nitroimidazole antibiotic	Microbial DNA (non-selective; requires anaerobic reduction)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (nitroimidazole antibiotic class)

Assistance Publique Hopitaux De Marseille · 1 drug in this class
Merck Sharp & Dohme LLC · 1 drug in this class
bioRASI, LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). placebo to metronidazole — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-metronidazole. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab